Screening Programmes for Chlamydia Not Adequate, Government Claims
Screening Programmes for Chlamydia Not Adequate, Government Claims

The Government today admitted that it has no idea if a programme to drive down Chlamydia infections is having an effect. In addition, it claimed that measures incorporated to keep a check on the progress of the screening programme across health trusts in England are not up to mark.

Chlamydia is the most common bacterial sexual infection and more than half of all new cases in 2008 were among under-25s. It can result in women to suffer pelvic inflammatory disease, infertility and ectopic pregnancies, if ignored.

Five years after the programme's launch, a mere 4.9 per cent of people aged 15 to 25 were being tested. However, the target was 15 per cent.

Today's report from MPs said, "Since the programme's launch an estimated £100m has been spent but the department does not yet know what effect, if any, this has had on reducing the prevalence of the infection”.

It is cited that the department lacks urgency in pushing PCT’s to touch a high volume of testing; revealing that the programme has not yet reached the level of activity where models augur that the prevalence of Chlamydia will be significantly reduced.

The report also suggested that the cost of testing varies between health trusts and there is incompetent commissioning of services and equipment.

 

Latest News

Nvidia to license graphics technology to other companies
AMD announces ‘Seattle’ microprocessor for server systems
First baby born using 'safer' IVF method
GM recalling 193,652 SUVs from model years 2006 and 2007
Microsoft Office will take time to become available on tablets
Ofsted-style ratings for hospitals
Google to reveal some details about its high-flying balloons
Strong competition between Microsoft and Sony is good for industry: EA
Alcohol-related disease patients deserve better care
U.S. Navy ditches ALL CAPS message format
Nokia to unveil 41MP camera-equipped Lumia EOS smartphone next month
From 2016, Britain to regulate e-cigarettes as medicine